Aspen Aerogels Files 8-K on Financials
Ticker: ASPN · Form: 8-K · Filed: Oct 16, 2024 · CIK: 1145986
| Field | Detail |
|---|---|
| Company | Aspen Aerogels Inc (ASPN) |
| Form Type | 8-K |
| Filed Date | Oct 16, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $670.6 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: AER
TL;DR
Aspen Aerogels dropped an 8-K on financials, check it for the latest.
AI Summary
Aspen Aerogels, Inc. filed an 8-K on October 16, 2024, to report on its results of operations and financial condition. The filing also includes disclosures related to Regulation FD, other events, and financial statements and exhibits. Specific financial details or operational updates were not detailed in the provided text excerpt.
Why It Matters
This filing provides an update on Aspen Aerogels' financial performance and operational status, which is crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — The filing is a standard disclosure and does not appear to contain immediate negative news or significant changes.
Key Players & Entities
- Aspen Aerogels, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- Northborough, MA (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing by Aspen Aerogels, Inc.?
The primary purpose of this 8-K filing is to report on Aspen Aerogels, Inc.'s results of operations and financial condition, along with disclosures related to Regulation FD, other events, and financial statements and exhibits.
On what date was this 8-K filing made?
This 8-K filing was made on October 16, 2024.
What is the state of incorporation for Aspen Aerogels, Inc.?
Aspen Aerogels, Inc. is incorporated in Delaware.
Where are the principal executive offices of Aspen Aerogels, Inc. located?
The principal executive offices of Aspen Aerogels, Inc. are located at 30 Forbes Road, Building B, Northborough, MA 01532.
What SEC Act is this filing made pursuant to?
This filing is made pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 805 words · 3 min read · ~3 pages · Grade level 11.1 · Accepted 2024-10-16 08:30:55
Key Financial Figures
- $670.6 million — gy ("DOE") for a proposed loan of up to $670.6 million under the Advanced Technology Vehicles
Filing Documents
- f8k_101624.htm (8-K) — 24KB
- exh_991.htm (EX-99.1) — 36KB
- 0001171843-24-005651.txt ( ) — 240KB
- aspn-20241016.xsd (EX-101.SCH) — 3KB
- aspn-20241016_lab.xml (EX-101.LAB) — 33KB
- aspn-20241016_pre.xml (EX-101.PRE) — 22KB
- f8k_101624_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On October 16, 2024, the Company issued a press release containing recent developments with its business and preliminary financial information for the third quarter ended September 30, 2024. A copy of the press release containing such announcement is attached hereto as Exhibit 99.1.
01 Other Events
Item 8.01 Other Events. The Company today announced that it has received a conditional commitment from the U.S. Department of Energy ("DOE") for a proposed loan of up to $670.6 million under the Advanced Technology Vehicles Manufacturing loan program within DOE's Loan Programs Office for financing the construction of its planned second aerogel manufacturing facility in Register, Georgia. Aspen Aerogels Georgia, LLC, a subsidiary of the Company, is the intended borrower of the loan. The loan would provide for repayment commencing upon project commissioning. The interest rate will be the applicable U.S. Treasury Rate at the time of each cash draw. While this conditional commitment indicates the DOE's intent to finance the project, the DOE and the Company must satisfy certain technical, legal, environmental, and financial conditions before the DOE enters into definitive financing documents and funds the loan.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release issued by Aspen Aerogels, Inc. on October 16, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) The press release may contain hypertext links to information on the Company's website. The information on its website is not incorporated by reference into this Current Report on Form 8-K and does not constitute a part of this Form 8-K. The information contained in Item 2.02 and Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that Section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Aspen Aerogels, Inc. Date: October 16, 2024 By: /s/ Ricardo C. Rodriguez Name: Ricardo C. Rodriguez Title: Chief Financial Officer and Treasurer